<DOC>
	<DOCNO>NCT01636128</DOCNO>
	<brief_summary>The purpose study determine effect 2 drug ( sulindac Difluoromethylornithine ( DFMO ) ) either alone combination biomarkers find urine .</brief_summary>
	<brief_title>Urinary Biomarker Study With Sulindac Difluoromethylornithine</brief_title>
	<detailed_description />
	<mesh_term>Sulindac</mesh_term>
	<mesh_term>Eflornithine</mesh_term>
	<criteria>Age 4065 year Fluent English PS 0 ECOG Must able discontinue use aspirin , aspirin contain product , nonsteroidal antiinflammatory agent duration study agent administration period Negative fecal occult blood test Hemoglobin &gt; 10g/dl , WBC must &gt; 4,000 mm3 , platelet must &gt; 100,000/mm3 Serum creatinine must &lt; 1.5 m/dl Serum bilirubin must &lt; 2.0 mg/dl , AST ALT must &lt; 1.5x upper limit normal range Female participant must postmenopausal ( least 1 year since last menstrual period ) , surgically sterilize , willing use effective birth control method ( e.g. , hormonal contraceptive , oral contraceptive , intrauterine device , diaphragm spermicide , abstinence ) duration study . Male subject must use effective method birth control throughout duration study impregnate female . Females childbearing potential must negative serum pregnancy test prior start study medication . Able give sign , write informed consent Requires corticosteroids nonsteroidal antiinflammatory agent Individuals immunosuppressed virtue medication disease . This include participant know AIDS , subject take oral steroid , subject immunosuppressants/immunomodulators ( cyclosporine , chemotherapeutic agent , biologic therapy ) Current use phenytoin sulfonamide Current recent ( within 3 month ) use coumadin systemic anticoagulant . Frequently , chronic moderate/severe gastric complaint . Upper gastrointestinal problem require prescription nonprescription medical remedy symptom heartburn , dyspepsia , nausea , abdominal pain &gt; per week average History peptic ulcer , occult gross intestinal bleeding Known intercurrent illness , include limited , inflammatory bowel disease , Crohn 's disease , ulcerative colitis , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , renal disease , liver disease , ongoing active infection , psychiatric illness , situation would limit compliance interfere ability comply study regimen . History bleed clot disorder Individuals seizure history seizure History abnormal wound heal repair , condition predispose include diabetes Unwilling unable limit alcohol consumption 23 serving per week study period ( 12oz beer , 1 oz per alcoholic beverage , 6 oz per wine ) Individuals enrol plan enroll clinical intervention trial . There must 30 day period complete previous study enrol study . Pregnant lactate woman Prior DFMO exposure History allergic reaction ( e.g. , urticaria , asthma , rhinitis ) gastric intolerance attribute NSAIDs</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Urinary</keyword>
	<keyword>biomarkers</keyword>
	<keyword>DFMO</keyword>
	<keyword>sulindac</keyword>
</DOC>